JPMorgan Chase & Co’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$49.5M Buy
783,559
+639,919
+446% +$40.4M ﹤0.01% 1216
2025
Q1
$7.61M Sell
143,640
-120,945
-46% -$6.41M ﹤0.01% 2372
2024
Q4
$14.8M Buy
264,585
+182,993
+224% +$10.2M ﹤0.01% 1955
2024
Q3
$4.27M Sell
81,592
-58,554
-42% -$3.07M ﹤0.01% 2730
2024
Q2
$5.75M Buy
140,146
+85,642
+157% +$3.52M ﹤0.01% 2448
2024
Q1
$2.36M Sell
54,504
-23,095
-30% -$1M ﹤0.01% 3050
2023
Q4
$3.57M Buy
77,599
+5,188
+7% +$238K ﹤0.01% 2781
2023
Q3
$1.66M Buy
72,411
+2,823
+4% +$64.7K ﹤0.01% 3109
2023
Q2
$1.15M Buy
69,588
+47,303
+212% +$780K ﹤0.01% 3346
2023
Q1
$398K Buy
22,285
+2,644
+13% +$47.2K ﹤0.01% 3948
2022
Q4
$572K Buy
19,641
+17,430
+788% +$508K ﹤0.01% 3681
2022
Q3
$54K Buy
2,211
+1,770
+401% +$43.2K ﹤0.01% 4677
2022
Q2
$2K Sell
441
-26,540
-98% -$120K ﹤0.01% 5424
2022
Q1
$312K Buy
26,981
+4,701
+21% +$54.4K ﹤0.01% 4229
2021
Q4
$223K Sell
22,280
-221
-1% -$2.21K ﹤0.01% 4481
2021
Q3
$293K Buy
22,501
+332
+1% +$4.32K ﹤0.01% 4229
2021
Q2
$434K Sell
22,169
-57,656
-72% -$1.13M ﹤0.01% 4074
2021
Q1
$1.7M Sell
79,825
-8,435
-10% -$180K ﹤0.01% 3336
2020
Q4
$2.62M Sell
88,260
-2,594
-3% -$77.1K ﹤0.01% 2801
2020
Q3
$2.02M Sell
90,854
-5,017
-5% -$112K ﹤0.01% 2753
2020
Q2
$2.14M Sell
95,871
-8,145
-8% -$182K ﹤0.01% 2644
2020
Q1
$1.58M Sell
104,016
-16,867
-14% -$257K ﹤0.01% 2716
2019
Q4
$2.78M Sell
120,883
-5,661
-4% -$130K ﹤0.01% 2509
2019
Q3
$2.73M Sell
126,544
-291
-0.2% -$6.28K ﹤0.01% 2565
2019
Q2
$2.75M Buy
126,835
+3,057
+2% +$66.3K ﹤0.01% 2492
2019
Q1
$3.39M Sell
123,778
-321
-0.3% -$8.8K ﹤0.01% 2338
2018
Q4
$3.34M Sell
124,099
-5,255
-4% -$141K ﹤0.01% 2343
2018
Q3
$3.77M Sell
129,354
-29,720
-19% -$867K ﹤0.01% 2408
2018
Q2
$4.97M Buy
159,074
+1,621
+1% +$50.7K ﹤0.01% 2249
2018
Q1
$3.13M Buy
157,453
+39,476
+33% +$786K ﹤0.01% 2498
2017
Q4
$3.43M Buy
+117,977
New +$3.43M ﹤0.01% 2476